RNDr. Pavel Krejčí, Ph.D.
Head of the research group, Pavel Krejčí Research Group
office: bldg. A19/231a
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 5395 |
---|---|
e‑mail: | krejcip@med.muni.cz |
social and academic networks: |
---|
Total number of publications: 127
2025
-
Protein structure and interactions elucidated with in-cell NMR for different cell cycle phases and in 3D human tissue models
Communications Biology, year: 2025, volume: 8, edition: 1, DOI
-
Specific inhibition of fibroblast growth factor receptor 1 signaling by a DNA aptamer
MOLECULAR THERAPY-NUCLEIC ACIDS, year: 2025, volume: 36, edition: 1, DOI
2024
-
Achondroplasia: aligning mouse model with human clinical studies shows crucial importance of immediate postnatal start of the therapy
Journal of bone and mineral research, year: 2024, volume: 39, edition: 12, DOI
-
Discovery of Two Highly Selective Structurally Orthogonal Chemical Probes for Activin Receptor-like Kinases 1 and 2
Journal of Medicinal Chemistry, year: 2024, volume: 67, edition: 15, DOI
-
eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations
Proceedings of the National Academy of Sciences of the United States of America, year: 2024, volume: 121, edition: 44, DOI
-
Ligand bias underlies differential signaling of multiple FGFs via FGFR1
elife, year: 2024, volume: 12, edition: April 2024, DOI
-
Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands
CYTOKINE & GROWTH FACTOR REVIEWS, year: 2024, volume: 78, edition: August 2024, DOI
2023
-
Lékařská biologie II. Genetika a molekulární medicína
Year: 2023, edition: Vyd. 1., number of pages: 227 s.
-
Nanodiamonds as artificial proteins for regulation of a cell signalling system
Publisher: European Patent Office, state: Germany, patent's number: EP3645018B1, year: 2023
-
Nanodiamonds as artificial proteins for regulation of a cell signalling system
Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11744855B2, year: 2023